Primary Prevention of Hypertension in Obese Adolescents
Obesity, Pre-Hypertension, Hyperuricemia
About this trial
This is an interventional treatment trial for Obesity
Eligibility Criteria
Inclusion Criteria: Children between the ages of 11 and 18 body mass index greater than the 95th percentile for age Blood pressure between 75th and 95th percentile for age, gender and height percentile Exclusion Criteria: hypertension at the time of screening allergy to one of the study medications liver function abnormality (AST or ALT greater than twice the upper limit of normal for the laboratory) history of renal stones renal insufficiency (Schwartz formula calculated GFR less than 70ml per min per 1.73m2 BSA) positive urine pregnancy test diabetes organ transplant recipient currently treated with an angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), diuretic, other medications known to alter serum uric acid level lack of ability to comply with the study protocol
Sites / Locations
- Texas Children's Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
Allopurinol
Probenecid
Placebo